Neeraja Danda

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma”.

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3241

N/A

0.464DataRank · unranked

21 citations

Roy E. Strowd, Burt Nabors, Benjamin M. Ellingson, Michael Chang, Sze Kiat Tan +13 more

Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf117

N/A

0.208DataRank · unranked

3 citations

Stuart A. Grossman, Angela Shaulov Kask, Samuel Kosydar, Roy E. Strowd, Anna F. Piotrowski +12 more

Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf041

N/A

0.165DataRank · unranked

2 citations

Carlos G. Romo, Xiaobu Ye, Brian G. Kral, Roy E. Strowd, Glenn J. Lesser +7 more